Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.

Zika virus infection continues to be a global concern for human health due to the high-risk association of the disease with neurological disorders and microcephaly in newborn. Nowadays, no vaccine or specific antiviral treatment is available, and the development of safe and effective vaccines is yet a challenge. In this study, we obtained a novel subunit vaccine that combines two regions of zika genome, domain III of the envelope and the capsid, in a chimeric protein in E. coli bacteria. The recombinant protein was characterized with polyclonal anti-ZIKV and anti-DENV antibodies that corroborate the specificity of the molecule. In addition, the PBMC from zika-immune donors stimulated with the ZEC recombinant antigen showed the capacity to recall the memory T cell response previously generated by the natural infection. The chimeric protein ZEC was able to self-assemble after combination with an immunomodulatory specific oligonucleotide to form aggregates. The inoculation of BALB/c mice with ZEC aggregated and not aggregated form of the protein showed a similar humoral immune response, although the aggregated variant induced more cell-mediated immunity evaluated by in vitro IFNγ secretion. In this study, we propose a novel vaccine candidate against the zika disease based on a recombinant protein that can stimulate both arms of the immune system.

A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.

Since the beginning of the COVID-19 pandemic, the development of effective vaccines against this pathogen has been a priority for the scientific community. Several strategies have been developed including vaccines based on recombinant viral protein fragments. The receptor-binding domain (RBD) in the S1 subunit of S protein has been considered one of the main targets of neutralizing antibodies. In this study we assess the potential of a vaccine formulation based on the recombinant RBD domain of SARS-CoV-2 expressed in the thermophilic filamentous fungal strain Thermothelomyces heterothallica and the hepatitis B virus (HBV) core protein. Functional humoral and cellular immune responses were detected in mice. To our knowledge, this is the first report on the immune evaluation of a biomedical product obtained in the fungal strain T. heterothallica. These results together with the intrinsic advantages of this expression platform support its use for the development of biotechnology products for medical purpose.

A Eurasian Mineralogy: Aleksandr Fersman's Conception of the Natural World.

Thoroughly a product of imperial Russia's aristocratic culture, the mineralogist and geochemist Aleksandr Fersman rose to the top of the country's scientific establishment after the Bolsheviks took control. He then remained a staunch supporter of various industrial projects through much of the Stalinist period. This essay puts Fersman's thinking about the natural world in conversation with a quite distinctive mode of intellectual inquiry that developed contemporaneously. Eurasianism was a philosophical doctrine of a group of Russian émigrés who emphasized Russia's unique status straddling Europe and Asia. While Fersman did not belong to this group of thinkers, a number of his ideas drew on specific experiences in the environments of the Eurasian landmass. Indeed, the article argues that Fersman's dualistic understanding of nature, his advocacy for the field of geochemistry, his definition of deserts, and a scheme he proposed for industrial operations owed much to the Eurasian settings of the science he practiced. Furthermore, this case of a Eurasian mineralogist illuminates novel aspects of the interplay between national and global sciences.